Technical Analysis for AMPE - Ampio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 0.52 -0.50% 0.00
AMPE closed down 0.5 percent on Friday, May 24, 2019, on 52 percent of normal volume.
5 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical AMPE trend table...

Date Alert Name Type % Chg
BB Squeeze Ended Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
20 DMA Resistance Bearish -0.50%
MACD Bearish Signal Line Cross Bearish -0.50%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.50%
Golden Cross Bullish -0.50%
Bollinger Band Squeeze Range Contraction -0.50%
NR7 Range Contraction -0.50%
Fell Below 20 DMA Bearish -3.77%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.77%

Older signals for AMPE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:

Profile
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of pharmaceutical drugs and diagnostic products to identify, treat, and prevent metabolic disorders, eye diseases, kidney diseases, acute and chronic inflammation diseases, and male sexual dysfunction. Its products include Ampion, a non-steroidal anti-inflammatory biologic to treat inflammatory conditions and autoimmune diseases; Optina, an orally administered danazol for the treatment of diabetic macular edema; Vasaloc for the treatment of diabetic nephropathy; and Zertane, an oral drug for treating male sexual dysfunction to premature ejaculation, which is under Phase III clinical trial. The company is also developing a handheld oxidation-reduction potential diagnostic device for use at home or in healthcare facilities that will measure the oxidants/antioxidant balances in human blood and plasma; and methylphenidate derivatives for cancer, which are in pre-clinical development. Ampio Pharmaceuticals, Inc. is headquartered in Greenwood Village, Colorado.
Health Biopharmaceutical Cancer Life Sciences Diabetes Autoimmune Diseases Healthcare Facilities Diagnostic Products Kidney Diseases Diabetic Nephropathy Macular Edema Diabetic Retinopathy Kidney Disease Metabolic Disorders Diabetic Macular Edema Eye Diseases Sexual Dysfunction
Is AMPE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 22 Ampio Clinical, Regulatory and Corporate Update
Apr 29 Ampio not quite there with confirmatory study of Ampion; shares down 5% premarket
Apr 29 Ampio Pharmaceuticals Provides Regulatory Update
Mar 27 The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO
Mar 26 Ampio Pharmaceuticals Provides Corporate Update
Feb 25 Research Report Identifies Wolverine World Wide, Viking Therapeutics, Ampio Pharmaceuticals, ArcelorMittal, Delphi Technologies, and Unit with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Feb 6 Ampio Updates Status of Pivotal Clinical Trial of Ampion to be Carried Out Under a SPA
Dec 13 FDA requires additional study of Ampio Pharma's Ampion to support marketing application; shares down 11% premarket
Dec 13 Ampio Updates Regulatory Status for Ampion
Nov 26 U.S. regulatory decision approaches for Ampio Pharma's Ampion
See more AMPE news...
Indicators
Indicator Value
52 Week High 3.2
52 Week Low 0.351
Average Volume 413,905
200-Day Moving Average 0.5411
50-Day Moving Average 0.5519
20-Day Moving Average 0.5411
10-Day Moving Average 0.5228
Average True Range 0.0425
ADX 12.53
+DI 11.5385
-DI 16.1908
Chandelier Exit (Long, 3 ATRs ) 0.4875
Chandelier Exit (Short, 3 ATRs ) 0.6175
Upper Bollinger Band 0.5893
Lower Bollinger Band 0.4929
Percent B (%b) 0.28
BandWidth 17.815561
MACD Line -0.0083
MACD Signal Line -0.008
MACD Histogram -0.0004
Fundamentals Value
Market Cap 35.48 Million
Num Shares 68.2 Million
EPS -0.21
Price-to-Earnings (P/E) Ratio -2.48
Price-to-Sales 0.00
Price-to-Book 19.82
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.58
Resistance 3 (R3) 0.58 0.56 0.57
Resistance 2 (R2) 0.56 0.54 0.56 0.57
Resistance 1 (R1) 0.54 0.53 0.53 0.54 0.56
Pivot Point 0.52 0.52 0.51 0.52 0.52
Support 1 (S1) 0.50 0.50 0.49 0.50 0.48
Support 2 (S2) 0.48 0.50 0.48 0.47
Support 3 (S3) 0.46 0.48 0.47
Support 4 (S4) 0.46